insights_auto
Why is EDIT up 3,97%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
2,62 $
arrow_upward
+3,97%(+0,100) 1D
2,60 $
arrow_downward
-0,76% (-0,020)bedtimeAfter hours
Closed: 2 հոկ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,57 $
High
2,63 $
Low
2,51 $
Mkt. cap
402,38 մլն
Avg. vol.
2,95 մլն
Volume
2,16 մլն
52-wk high
4,54 $
52-wk low
1,66 $
EPS
-0,74 $
Beta
2,00
Shares outstanding
153,58 մլն
No. of employees
87
Open
2,57 $
High
2,63 $
Low
2,51 $
Mkt. cap
402,38 մլն
Avg. vol.
2,95 մլն
Volume
2,16 մլն
52-wk high
4,54 $
52-wk low
1,66 $
EPS
-0,74 $
Beta
2,00
Shares outstanding
153,58 մլն
No. of employees
87
News stories
From web sources and news partners
MarketBeat
·
4 րոպե առաջ
Xometry (NASDAQ:XMTR) CEO Sanjeev Singh Sahni Sells 1,112 Shares of Stock
Simply Wall Street
·
50 րոպե առաջ
Ionis Pharmaceuticals Fell 45% With The Case Still Split
Moomoo
·
1 ժամ առաջ
Chip-Led Rally Lifts Nasdaq; Tesla Jumps 4.65%
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc